The US Food and Drug Administration (FDA) has released draft guidance on how sponsors can utilize next-generation sequencing ...
This review examines how next-generation protein sequencing and analysis technologies are expanding proteomics beyond the ...
The results are transforming how scholars understand human history. By analysing parchment, researchers are uncovering ...
The document outlines the non-clinical sequencing and bioinformatics data sponsors need to submit as part of INDs and BLAs for gene-editing therapies.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results